Crossmark

Effectiveness of IV cyclophosphamide and mycophenolate mofetil in the treatment of childhood-onset lupus nephritis in a resource-limited setting

Published Online: 2026-02-24

Authors

Guiang-Valerio, Adrienne Katrin M.

Collante, Ma. Theresa M.

Bernal, Christine B.
License Information

Text and Data Mining valid from 2026-02-24

Version of Record valid from 2026-03-19
More Information

Article History

Received: 18 December 2025

Accepted: 19 February 2026

First Online: 24 February 2026

Declarations

:

: The study was submitted to the Research Ethics Committee of the University of Santo Tomas Hospital (USTH-REC) and was given approval with protocol reference number REC-2024-10-142-TF-FR-AP. This study was done in compliance with the ethical principles set by the World Medical Association (WMA) in the Declaration of Helsinki (2013), the WHO Operational Guidelines, the National Ethical Guidelines for Research Involving Human Participants 2022 (NEGRHIP 2022) and the ICH - Good Clinical Practice.

: Not applicable.

: The authors declare no competing interests.

Document is current